BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 973163)

  • 1. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete regression of melanoma associated with vitiligo.
    Piqué-Duran E; Palacios-Llopis S; Martínez-Martín M; Pérez-Cejudo JA
    Dermatol Online J; 2011 Jan; 17(1):4. PubMed ID: 21272495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant melanoma, leukoderma and vitiligo].
    Kraus L; Landthaler M
    Z Hautkr; 1980 Feb; 55(4):218-31. PubMed ID: 6996365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma and vitiligo.
    Balabanov K; Andreev VC; Tchernozemski I
    Dermatologica; 1969; 139(3):211-9. PubMed ID: 5808472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spontaneous regression and leukoderma in malignant melanoma].
    Happle R; Schotola I; Macher E
    Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitiligo and malignant melanoma (author's transl)].
    Hamm G; Fiedler H
    Dermatol Monatsschr; 1979 Dec; 165(12):838-42. PubMed ID: 546664
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexisting malignant melanoma and vitiligo in a Nigerian.
    Alabi GO; Falope ZF; Lekwauwa UG
    West Afr J Med; 1991; 10(1):443-6. PubMed ID: 2069894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
    Brandt O; Christophers E; Fölster-Holst R
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S101-4. PubMed ID: 15858503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo and malignant melanoma.
    Fodor J; Bodrogi I
    Neoplasma; 1975; 22(4):445-8. PubMed ID: 1196428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo.
    Cooke KB; Bennett C; Staughton RC
    Br J Dermatol; 1978 Jun; 98(6):663-8. PubMed ID: 678452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of a congenital giant hairy nevus and extensive vitiligo.
    Grefer K; Hofmann M; Sterry W; Trefzer U
    Dermatology; 2003; 207(2):199-201. PubMed ID: 12920375
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 13. Iritis in patients with cutaneous melanoma and vitiligo.
    Albert DM; Sober AJ; Fitzpatrick TB
    Arch Ophthalmol; 1978 Nov; 96(11):2081-4. PubMed ID: 718499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous achromia and malignant melanoma].
    Barrière H; Litoux P; Le Lay M; Bureau B; Stalder JF; Dreno B
    Ann Dermatol Venereol; 1984; 111(11):991-6. PubMed ID: 6524818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo associated with malignant melanoma and lupus erythematosus.
    Gül U; Kiliç A; Tulunay O; Kaygusuz G
    J Dermatol; 2007 Feb; 34(2):142-5. PubMed ID: 17239155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
    Mitchell MS; Nordlund JJ; Lerner AB
    J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo or halo nevi occurring in two patients with choroidal melanoma.
    Albert DM; Todes-Taylor N; Wagoner M; Nordlund JJ; Lerner AB
    Arch Dermatol; 1982 Jan; 118(1):34-6. PubMed ID: 7059198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanoma and HIV infection].
    Rasokat H; Steigleder GK; Bendick C; Müller S; Meller M
    Z Hautkr; 1989 Jul; 64(7):581-2, 587. PubMed ID: 2528242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
    Rosenberg SA; White DE
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):81-4. PubMed ID: 8859727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.